Alzheimer’s Disease Diagnostic Market is poised to value at a CAGR of over 6.2% during the forecast period 2022 to 2028.

It has been found that Alzheimer's disease (AD) is the most common cause of progressive dementia in the elderly. In recent years, the number of Alzheimer's disease cases has skyrocketed around the world, which stresses the necessity for cultivating useful drugs to treat it. The growing number of old people around the world is a primary factor fueling the growth of the Alzheimer's disease diagnostic market in years to come. Growing life expectancy is causing a rapid rise in the number of elderly people and is connected to the increase in chronic diseases such as dementia. Despite these factors, factors such as the limited recognition of Alzheimer's disease's key causes and mechanisms, and the high costs associated with diagnosis, are likely to hamper the growth of the Alzheimer's disease diagnostic market. Further, Alzheimer's disease treatments provide temporary and unclear improvements in the comfort of individuals, and there are no approved drugs that can alter the pattern of the disease's development. The growth of the Alzheimer's disease diagnostic market is thus a lucrative opportunity for drug manufacturers. Diagnostic facilities are one of the most significant obstacles preventing patients with Alzheimer's dementia from receiving basic care, which is a huge challenge for the growth of the Alzheimer's disease diagnostic market. The lack of skilled medical specialists in developing countries is another problem. The lack of knowledge regarding the new treatments used to treat Alzheimer's disease also poses a substantial challenge to the growth of the global Alzheimer's disease diagnostics market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Alzheimer’s Disease Diagnostic Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Alzheimer’s Disease Diagnostic Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Alzheimer’s Disease Diagnostic Market:
• TauRx
• Alector LLC
• Eli Lilly and Company
• Treventis Corporation
• Neuro-Bio Ltd
• Accera, Inc.
• Cognition Therapeutics Inc.
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd
• Quanterix
• Sysmex
• Novartis AG
• Allergan PLC
• C2N Dignostics
• Randox Bioscience
• GE Healthcare
• Hitachi
(Note: The list of the major players will be updated with the latest market scenario and trends)

Alzheimer’s Disease Diagnostic Market Segmentation:
By Product Type
• Brain Imaging
• CFS Test for Alzheimer's Disease
By Type  
• Early-Onset
• Late-Onset
• Familial
By End-Use
• Hospitals
• Specialty Clinics/ Diagnostic Centers
• Ambulatory Surgical Centers
• Academic & Research Institutes

By Region
• North America
• Europe
• Latin America
• Middle East and Africa

Alzheimer’s Disease Diagnostic Market Sample Video:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Alzheimer’s Disease Diagnostic Market By Product Type, By Type, By End-Use and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics